Assaf P. Oron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Assaf P. Oron has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Nancy Flournoy
University of Missouri, Bellingham, USA
2 shared publications - Adam A. Szpiro
University of Washington, Seattle, USA
1 shared publication Aditi Apte
Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India
1 shared publicationAmanda S. Izzo
Affiliation Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, Washington, United States of America
1 shared publication- Amelie O. von Saint Andre-Von Arnim
Department of Pediatrics, Division of Critical Care Medicine and University of Washington, Seattle Children’s Hospital, United States
1 shared publication - Anand Kawade
Community Health Research Unit Pune Maharashtra 411020 KEM Hospital Research Centre
1 shared publication
Latest Publications
- Open Access
- 30 December 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 04235
Prediction of inpatient mortality in hospitalised children in low- and middle-income countries: An external validation of paediatric mortality risk scores
Despite considerable reductions in global child deaths over the past decades, child mortality remains high in many low- and middle-income countries (LMICs) [1] with inpatient case fatality from acute illness as high as 10%, largely due to preventable and treatable conditions such as malaria, pneumonia, and diarrheal diseases [2]. Deaths in hospitalised children often occur […]
- 30 December 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 04235
Open AccessPrediction of inpatient mortality in hospitalised children in low- and middle-income countries: An external validation of paediatric mortality risk scores
Despite considerable reductions in global child deaths over the past decades, child mortality remains high in many low- and middle-income countries (LMICs) [1] with inpatient case fatality from acute illness as high as 10%, largely due to preventable and treatable conditions such as malaria, pneumonia, and diarrheal diseases [2]. Deaths in hospitalised children often occur […]
- Open Access
- 17 December 2024
- Published by New England Statistical Society in The New England Journal of Statistics in Data Science
- p. 222-233
Up-and-Down: The Most Popular, Most Reliable, and Most Overlooked Dose-Finding Design
Up-and-Down designs (UDDs) are ubiquitous for dose-finding in a wide variety of scientific, engineering, and clinical fields. They are defined by a few simple rules that generate a random walk around the target percentile. UDDs’ combination of robust, tractable behavior, straightforward usage, and good dose-finding performance, has won the trust of practitioners and their consulting analysts across fields and continents. In contrast, in recent decades the statistical dose-finding design field has turned a cold shoulder towards UDDs, and it is quite possible that many younger dose-finding methods researchers are not even aware of this design approach. We present a concise overview of UDDs and their current state-of-the-art methodology, with references for further inquiry. We also revisit the performance comparison between UDDs and novel, more complicated design approaches such as the Continual Reassessment Method and the Bayesian Optimal Interval design, which we group under the term “Aim-for-Target” designs. UDDs fare very well in the comparison, particularly in terms of robustness to sources of variability.
- 17 December 2024
- Published by New England Statistical Society in The New England Journal of Statistics in Data Science
- p. 222-233
Open AccessUp-and-Down: The Most Popular, Most Reliable, and Most Overlooked Dose-Finding Design
Up-and-Down designs (UDDs) are ubiquitous for dose-finding in a wide variety of scientific, engineering, and clinical fields. They are defined by a few simple rules that generate a random walk around the target percentile. UDDs’ combination of robust, tractable behavior, straightforward usage, and good dose-finding performance, has won the trust of practitioners and their consulting analysts across fields and continents. In contrast, in recent decades the statistical dose-finding design field has turned a cold shoulder towards UDDs, and it is quite possible that many younger dose-finding methods researchers are not even aware of this design approach. We present a concise overview of UDDs and their current state-of-the-art methodology, with references for further inquiry. We also revisit the performance comparison between UDDs and novel, more complicated design approaches such as the Continual Reassessment Method and the Bayesian Optimal Interval design, which we group under the term “Aim-for-Target” designs. UDDs fare very well in the comparison, particularly in terms of robustness to sources of variability.
- Open Access
- 12 September 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (4) , 863-872
Potential Impacts of Mass Nutritional Supplementation on Measles Dynamics: A Simulation Study
: The bidirectional interaction between undernutrition and infection can be devastating to child health. Nutritional deficiencies impair immunity and increase susceptibility to infection. Simultaneously, infections compound undernutrition by increasing metabolic demand and impairing nutrient absorption. Treatment of acute malnutrition (wasting) can reverse some of its deleterious effects and reduce susceptibility to infectious diseases. Nutrition-specific approaches may be packaged with other interventions, including immunization, to support overall child health. To understand how mass nutritional supplementation, treatment of wasting, and vaccination affect the dynamics of a vaccine-preventable infection, we developed a population-level, compartmental model of measles transmission stratified by age and nutrition status. We simulated a range of scenarios to assess the potential reductions in measles infection and mortality associated with targeted therapeutic feeding for children who are wasted and with a mass supplementation intervention. Nutrition interventions were assumed to increase engagement with the health sector, leading to increased vaccination rates. We found that the combination of wasting treatment and mass supplementation coverage followed by an increase in vaccination coverage of non-wasted children from a baseline of 75% to 85%, leads to 34% to 57% and 65% to 77% reduction in measles infection and mortality and 56% to 60% reduction in overall mortality among wasted children, compared with the wasting treatment alone. Our work highlights the synergistic benefits that may be achieved by leveraging mass nutritional supplementation as a touch point with the health system to increase rates of vaccination and improve child survival beyond what would be expected from the additive benefits of each intervention.
- 12 September 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (4) , 863-872
Open AccessPotential Impacts of Mass Nutritional Supplementation on Measles Dynamics: A Simulation Study
: The bidirectional interaction between undernutrition and infection can be devastating to child health. Nutritional deficiencies impair immunity and increase susceptibility to infection. Simultaneously, infections compound undernutrition by increasing metabolic demand and impairing nutrient absorption. Treatment of acute malnutrition (wasting) can reverse some of its deleterious effects and reduce susceptibility to infectious diseases. Nutrition-specific approaches may be packaged with other interventions, including immunization, to support overall child health. To understand how mass nutritional supplementation, treatment of wasting, and vaccination affect the dynamics of a vaccine-preventable infection, we developed a population-level, compartmental model of measles transmission stratified by age and nutrition status. We simulated a range of scenarios to assess the potential reductions in measles infection and mortality associated with targeted therapeutic feeding for children who are wasted and with a mass supplementation intervention. Nutrition interventions were assumed to increase engagement with the health sector, leading to increased vaccination rates. We found that the combination of wasting treatment and mass supplementation coverage followed by an increase in vaccination coverage of non-wasted children from a baseline of 75% to 85%, leads to 34% to 57% and 65% to 77% reduction in measles infection and mortality and 56% to 60% reduction in overall mortality among wasted children, compared with the wasting treatment alone. Our work highlights the synergistic benefits that may be achieved by leveraging mass nutritional supplementation as a touch point with the health system to increase rates of vaccination and improve child survival beyond what would be expected from the additive benefits of each intervention.
- Top Cited Papers
- 13 July 2022
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 137 (2) , 137-150
Understanding Research Methods: Up-and-down Designs for Dose-finding
Summary: For the task of estimating a target benchmark dose such as the ED50 (the dose that would be effective for half the population), an adaptive dose-finding design is more effective than the standard approach of treating equal numbers of patients at a set of equally spaced doses. Up-and-down is the most popular family of dose-finding designs and is in common use in anesthesiology. Despite its widespread use, many aspects of up-and-down are not well known, implementation is often misguided, and standard, up-to-date reference material about the design is very limited. This article provides an overview of up-and-down properties, recent methodologic developments, and practical recommendations, illustrated with the help of simulated examples. Additional reference material is offered in the Supplemental Digital Content.
- 13 July 2022
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 137 (2) , 137-150
Top Cited PapersUnderstanding Research Methods: Up-and-down Designs for Dose-finding
Summary: For the task of estimating a target benchmark dose such as the ED50 (the dose that would be effective for half the population), an adaptive dose-finding design is more effective than the standard approach of treating equal numbers of patients at a set of equally spaced doses. Up-and-down is the most popular family of dose-finding designs and is in common use in anesthesiology. Despite its widespread use, many aspects of up-and-down are not well known, implementation is often misguided, and standard, up-to-date reference material about the design is very limited. This article provides an overview of up-and-down properties, recent methodologic developments, and practical recommendations, illustrated with the help of simulated examples. Additional reference material is offered in the Supplemental Digital Content.
- Top Cited PapersOpen Access
- 26 July 2021
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (7) , e1009149
Covasim: An agent-based model of COVID-19 dynamics and interventions
The COVID-19 pandemic has created an urgent need for models that can project epidemic trends, explore intervention scenarios, and estimate resource needs. Here we describe the methodology of Covasim (COVID-19 Agent-based Simulator), an open-source model developed to help address these questions. Covasim includes country-specific demographic information on age structure and population size; realistic transmission networks in different social layers, including households, schools, workplaces, long-term care facilities, and communities; age-specific disease outcomes; and intrahost viral dynamics, including viral-load-based transmissibility. Covasim also supports an extensive set of interventions, including non-pharmaceutical interventions, such as physical distancing and protective equipment; pharmaceutical interventions, including vaccination; and testing interventions, such as symptomatic and asymptomatic testing, isolation, contact tracing, and quarantine. These interventions can incorporate the effects of delays, loss-to-follow-up, micro-targeting, and other factors. Implemented in pure Python, Covasim has been designed with equal emphasis on performance, ease of use, and flexibility: realistic and highly customized scenarios can be run on a standard laptop in under a minute. In collaboration with local health agencies and policymakers, Covasim has already been applied to examine epidemic dynamics and inform policy decisions in more than a dozen countries in Africa, Asia-Pacific, Europe, and North America.
- 26 July 2021
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (7) , e1009149
Top Cited PapersOpen AccessCovasim: An agent-based model of COVID-19 dynamics and interventions
The COVID-19 pandemic has created an urgent need for models that can project epidemic trends, explore intervention scenarios, and estimate resource needs. Here we describe the methodology of Covasim (COVID-19 Agent-based Simulator), an open-source model developed to help address these questions. Covasim includes country-specific demographic information on age structure and population size; realistic transmission networks in different social layers, including households, schools, workplaces, long-term care facilities, and communities; age-specific disease outcomes; and intrahost viral dynamics, including viral-load-based transmissibility. Covasim also supports an extensive set of interventions, including non-pharmaceutical interventions, such as physical distancing and protective equipment; pharmaceutical interventions, including vaccination; and testing interventions, such as symptomatic and asymptomatic testing, isolation, contact tracing, and quarantine. These interventions can incorporate the effects of delays, loss-to-follow-up, micro-targeting, and other factors. Implemented in pure Python, Covasim has been designed with equal emphasis on performance, ease of use, and flexibility: realistic and highly customized scenarios can be run on a standard laptop in under a minute. In collaboration with local health agencies and policymakers, Covasim has already been applied to examine epidemic dynamics and inform policy decisions in more than a dozen countries in Africa, Asia-Pacific, Europe, and North America.
- 1 August 2019
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 47 (13-15) , 2431-2442
Bias induced by adaptive dose-finding designs
There is a long literature on bias in maximum likelihood estimators. Here we demonstrate that adaptive dose-finding procedures (such as Continual Reassessment Methods, Up-and-Down and Interval Designs) themselves induce bias. In particular, with Bernoulli responses and dose assignments that depend on prior responses, we provide an explicit formula for the bias of observed response rates. We illustrate the patterns of bias for designs that aim to concentrate dose allocations around a target dose, which represents a specific quantile of a cumulative response-threshold distribution. For such designs, bias tends to be positive above the target dose and negative below it. To our knowledge, this property of dose-finding designs has not previously been recognized by design developers. We discuss the implications of this bias and suggest a simple shrinkage mitigation formula that improves estimation at doses away from the target.
- 1 August 2019
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 47 (13-15) , 2431-2442
Bias induced by adaptive dose-finding designs
There is a long literature on bias in maximum likelihood estimators. Here we demonstrate that adaptive dose-finding procedures (such as Continual Reassessment Methods, Up-and-Down and Interval Designs) themselves induce bias. In particular, with Bernoulli responses and dose assignments that depend on prior responses, we provide an explicit formula for the bias of observed response rates. We illustrate the patterns of bias for designs that aim to concentrate dose allocations around a target dose, which represents a specific quantile of a cumulative response-threshold distribution. For such designs, bias tends to be positive above the target dose and negative below it. To our knowledge, this property of dose-finding designs has not previously been recognized by design developers. We discuss the implications of this bias and suggest a simple shrinkage mitigation formula that improves estimation at doses away from the target.
- Open Access
- 1 April 2015
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 5 (4) , 185-192
Variation in the Use of Procedural Sedation for Incision and Drainage of Skin and Soft Tissue Infection in Pediatric Emergency Departments
Objectives: Little is known about procedural sedation use for anxiety and pain associated with skin and soft tissue infections (SSTIs) requiring incision and drainage (I&D). Our objectives were therefore (1) to characterize the use of procedural sedation use for SSTI I&D procedures in pediatric emergency departments (EDs), (2) to compare the frequency of procedural sedation for I&D across hospitals, and (3) to determine factors associated with use of procedural sedation for I&D. Methods: We performed a retrospective cohort study of pediatric EDs contributing to the Pediatric Health Information Systems database in 2010. Cases were identified by primary International Classification of Diseases, 9th revision, Clinical Modification procedure codes for I&D. We used descriptive statistics to describe procedural sedation use across hospitals and logistic generalized linear mixed models to identify factors associated with use of procedural sedation. Results: There were 6322 I&D procedures, and procedural sedation was used in 24% of cases. Hospital-level use of procedural sedation varied widely, with a range of 2% to 94% (median 17%). Procedural sedation use was positively associated with sensitive body site, female gender, and employer-based insurance, and negatively associated with African American race and increasing age. Estimates of hospital-level use of procedural sedation for a referent case eliminating demographic differences exhibit similar variability with a range of 5% to 97% (median 34%). Conclusions: Use of procedural sedation for SSTI I&D varies widely across pediatric EDs, and the majority of variation is independent of demographic differences. Additional work is needed to understand decision-making and to standardize delivery of procedural sedation in children requiring I&D.
- 1 April 2015
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 5 (4) , 185-192
Open AccessVariation in the Use of Procedural Sedation for Incision and Drainage of Skin and Soft Tissue Infection in Pediatric Emergency Departments
Objectives: Little is known about procedural sedation use for anxiety and pain associated with skin and soft tissue infections (SSTIs) requiring incision and drainage (I&D). Our objectives were therefore (1) to characterize the use of procedural sedation use for SSTI I&D procedures in pediatric emergency departments (EDs), (2) to compare the frequency of procedural sedation for I&D across hospitals, and (3) to determine factors associated with use of procedural sedation for I&D. Methods: We performed a retrospective cohort study of pediatric EDs contributing to the Pediatric Health Information Systems database in 2010. Cases were identified by primary International Classification of Diseases, 9th revision, Clinical Modification procedure codes for I&D. We used descriptive statistics to describe procedural sedation use across hospitals and logistic generalized linear mixed models to identify factors associated with use of procedural sedation. Results: There were 6322 I&D procedures, and procedural sedation was used in 24% of cases. Hospital-level use of procedural sedation varied widely, with a range of 2% to 94% (median 17%). Procedural sedation use was positively associated with sensitive body site, female gender, and employer-based insurance, and negatively associated with African American race and increasing age. Estimates of hospital-level use of procedural sedation for a referent case eliminating demographic differences exhibit similar variability with a range of 5% to 97% (median 34%). Conclusions: Use of procedural sedation for SSTI I&D varies widely across pediatric EDs, and the majority of variation is independent of demographic differences. Additional work is needed to understand decision-making and to standardize delivery of procedural sedation in children requiring I&D.
- 20 October 2014
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2014 (1)
A Unified Spatiotemporal Modeling Approach for Prediction of Multiple Air Pollutants in MESA Air
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.
- 20 October 2014
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2014 (1)
A Unified Spatiotemporal Modeling Approach for Prediction of Multiple Air Pollutants in MESA Air
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.
- Open Access
- 23 January 2013
- Published by SAGE Publications in Clinical Trials
- Vol. 10 (1) , 63-80
Small-sample behavior of novel phase I cancer trial designs
Background: Novel dose-finding designs for Phase I cancer clinical trials, using estimation to assign the best estimated Maximum Tolerated Dose (MTD) at each point in the experiment, most prominently via Bayesian techniques, have been widely discussed and promoted since 1990. Purpose: To examine the small-sample behavior of these ‘Bayesian Phase I’ designs, and also of non-Bayesian designs sharing the same main ‘Long-Memory’ traits of using likelihood estimation and assigning the estimated MTD to the next patient. Methods: Data from several recently published experiments are presented and discussed, and Long-Memory designs’ operating principles are explained. Simulation studies compare the small-sample behavior of Long-Memory designs with short-memory ‘Up-and-Down’ designs. Results: In simulation, Long-Memory and Up-and-Down designs achieved similar success rates in finding the MTD. However, for all Long-Memory designs examined, the number n* of cohorts treated at the true MTD was highly variable between simulated experiments drawn from the same toxicity-threshold distribution. Further investigation using the same set of thresholds in permuted order indicates that this Long-Memory behavior is driven by sensitivity to the order in which participants enter the experiment. This sensitivity is related to Long-Memory designs’ ‘winner-takes-all’ dose-assignment rule, which grants the early cohorts a disproportionately large influence, and causes many experiments to settle early on a specific dose. Additionally for the Bayesian Long-Memory designs, the prior-predictive distribution over the dose levels has a substantial impact upon MTD-finding performance, long into the experiment. Limitations: While the numerical evidence for Long-Memory designs’ order sensitivity is broad, and plausible explanations for it are provided, we do not present a theoretical proof of the phenomenon. Conclusions: Method developers, analysts, and practitioners should be aware of Long-Memory designs’ order sensitivity and related phenomena. In particular, they should be informed that settling on a single dose does not guarantee that this dose is the MTD. Presently, Up-and-Down designs offer a simpler and more robust alternative for the sample sizes of 10–40 patients used in most Phase I trials. Future designs might benefit from combining the two approaches. We also suggest that the field’s paradigm change from dose-selection to dose-estimation.
- 23 January 2013
- Published by SAGE Publications in Clinical Trials
- Vol. 10 (1) , 63-80
Open AccessSmall-sample behavior of novel phase I cancer trial designs
Background: Novel dose-finding designs for Phase I cancer clinical trials, using estimation to assign the best estimated Maximum Tolerated Dose (MTD) at each point in the experiment, most prominently via Bayesian techniques, have been widely discussed and promoted since 1990. Purpose: To examine the small-sample behavior of these ‘Bayesian Phase I’ designs, and also of non-Bayesian designs sharing the same main ‘Long-Memory’ traits of using likelihood estimation and assigning the estimated MTD to the next patient. Methods: Data from several recently published experiments are presented and discussed, and Long-Memory designs’ operating principles are explained. Simulation studies compare the small-sample behavior of Long-Memory designs with short-memory ‘Up-and-Down’ designs. Results: In simulation, Long-Memory and Up-and-Down designs achieved similar success rates in finding the MTD. However, for all Long-Memory designs examined, the number n* of cohorts treated at the true MTD was highly variable between simulated experiments drawn from the same toxicity-threshold distribution. Further investigation using the same set of thresholds in permuted order indicates that this Long-Memory behavior is driven by sensitivity to the order in which participants enter the experiment. This sensitivity is related to Long-Memory designs’ ‘winner-takes-all’ dose-assignment rule, which grants the early cohorts a disproportionately large influence, and causes many experiments to settle early on a specific dose. Additionally for the Bayesian Long-Memory designs, the prior-predictive distribution over the dose levels has a substantial impact upon MTD-finding performance, long into the experiment. Limitations: While the numerical evidence for Long-Memory designs’ order sensitivity is broad, and plausible explanations for it are provided, we do not present a theoretical proof of the phenomenon. Conclusions: Method developers, analysts, and practitioners should be aware of Long-Memory designs’ order sensitivity and related phenomena. In particular, they should be informed that settling on a single dose does not guarantee that this dose is the MTD. Presently, Up-and-Down designs offer a simpler and more robust alternative for the sample sizes of 10–40 patients used in most Phase I trials. Future designs might benefit from combining the two approaches. We also suggest that the field’s paradigm change from dose-selection to dose-estimation.